81_FR_60883 81 FR 60712 - National Institute on Drug Abuse; Notice of Closed Meeting

81 FR 60712 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 171 (September 2, 2016)

Page Range60712-60712
FR Document2016-21121

Federal Register, Volume 81 Issue 171 (Friday, September 2, 2016) 
[Federal Register Volume 81, Number 171 (Friday, September 2, 2016)]
[Notices]
[Page 60712]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-21121]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Identification of Genetic and Genomic Variants by 
Next-Gen Sequencing in Non-Human Animal Models (U01).
    Date: September 23, 2016.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4234, MSC 
9550, Bethesda, MD 02892, 301-443-9511, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: August 29, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-21121 Filed 9-1-16; 8:45 am]
 BILLING CODE 4140-01-P

60712 Federal Register / Vol. 81, No. 171 / Friday, September 2, 2016 / Notices Program, Division of Extramural Activities, Dated: August 29, 2016. DEPARTMENT OF HEALTH AND Room 3G42A, National Institutes of Health/ Natasha M. Copeland, HUMAN SERVICES NIAID, 5601 Fishers Lane, MSC 9823, Program Analyst, Office of Federal Advisory Bethesda, MD 20892–9823, (240) 669–5069, National Institutes of Health Committee Policy. lrust@niaid.nih.gov. [FR Doc. 2016–21118 Filed 9–1–16; 8:45 am] (Catalogue of Federal Domestic Assistance National Eye Institute; Notice of BILLING CODE 4140–01–P Program Nos. 93.855, Allergy, Immunology, Meeting and Transplantation Research; 93.856, Microbiology and Infectious Diseases Pursuant to section 10(d) of the Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as HUMAN SERVICES amended (5 U.S.C. App.), notice is Dated: August 29, 2016. National Institutes of Health hereby given of a meeting of the Natasha M. Copeland, National Advisory Eye Council. Program Analyst, Office of Federal Advisory National Institute on Drug Abuse; Committee Policy. The meeting will be open to the Notice of Closed Meeting public as indicated below, with [FR Doc. 2016–21120 Filed 9–1–16; 8:45 am] attendance limited to space available. BILLING CODE 4140–01–P Pursuant to section 10(d) of the Individuals who plan to attend and Federal Advisory Committee Act, as need special assistance, such as sign amended (5 U.S.C. App), notice is language interpretation or other DEPARTMENT OF HEALTH AND hereby given of the following meeting. HUMAN SERVICES reasonable accommodations, should The meeting will be closed to the notify the Contact Person listed below National Institutes of Health public in accordance with the in advance of the meeting. provisions set forth in sections The meeting will be closed to the National Institute of Allergy and 552b(c)(4) and 552b(c)(6), title 5 U.S.C., public in accordance with the Infectious Diseases Notice of Closed as amended. The grant applications and provisions set forth in sections Meeting the discussions could disclose 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., confidential trade secrets or commercial as amended. The grant applications and Pursuant to section 10(d) of the property such as patentable material, Federal Advisory Committee Act, as the discussions could disclose and personal information concerning confidential trade secrets or commercial amended (5 U.S.C. App.), notice is individuals associated with the grant property such as patentable material, hereby given of the following meeting. applications, the disclosure of which and personal information concerning The meeting will be closed to the would constitute a clearly unwarranted individuals associated with the grant public in accordance with the invasion of personal privacy. provisions set forth in sections applications, the disclosure of which 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Name of Committee: National Institute on would constitute a clearly unwarranted as amended. The grant applications and Drug Abuse Special Emphasis Panel; invasion of personal privacy. the discussions could disclose Identification of Genetic and Genomic Name of Committee: National Advisory Variants by Next-Gen Sequencing in Non- confidential trade secrets or commercial Eye Council. Human Animal Models (U01). property such as patentable material, Date: October 20, 2016. Date: September 23, 2016. and personal information concerning Open: 8:30 a.m. to 1:00 p.m. Time: 12:00 p.m. to 4:00 p.m. individuals associated with the grant Agenda: Following opening remarks by the Agenda: To review and evaluate grant applications, the disclosure of which Director, NEI, there will be presentations by applications. would constitute a clearly unwarranted the staff of the Institute and discussions Place: National Institutes of Health, invasion of personal privacy. concerning Institute programs. Neuroscience Center, 6001 Executive Place: National Institutes of Health, Name of Committee: National Institute of Boulevard, Rockville, MD 20852 (Telephone Terrace Level Conference Rooms, 5635 Allergy and Infectious Diseases Special Conference Call). Fishers Lane, Bethesda, MD 20892. Emphasis Panel; NIAID Clinical Trial Contact Person: Jagadeesh S. Rao, Ph.D., Implementation Cooperative Agreement Closed: 1:00 p.m. to 5:00 p.m. Scientific Review Officer, Office of (U01). Agenda: To review and evaluate grant Extramural Policy and Review, Division of Date: October 27, 2016. applications. Extramural Research, National Institute on Time: 8:30 a.m. to 10:30 a.m. Place: National Institutes of Health, Drug Abuse, National Institutes of Health, Agenda: To review and evaluate grant Terrace Level Conference Rooms, 5635 DHHS, 6001 Executive Boulevard, Room applications. Fishers Lane, Bethesda, MD 20892. 4234, MSC 9550, Bethesda, MD 02892, 301– Place: National Institutes of Health, 5601 Contact Person: Paul A. Sheehy, Ph.D., 443–9511, jrao@nida.nih.gov. Fishers Lane, Rockville, MD 20892 Director, Division of Extramural Affairs, (Telephone Conference Call). (Catalogue of Federal Domestic Assistance National Eye Institute, National Institutes of Contact Person: Lynn Rust, Ph.D., Program Nos.: 93.279, Drug Abuse and Health, 5635 Fishers Lane, Suite 12300, Scientific Review Officer Scientific Review Addiction Research Programs, National Bethesda, MD 20892, 301–451–2020, ps32h@ Program, Division of Extramural Activities, Institutes of Health, HHS) nih.gov. Room 3G42A National Institutes of Health/ Dated: August 29, 2016. Information is also available on the mstockstill on DSK3G9T082PROD with NOTICES NIAID, 5601 Fishers Lane, MSC 9823, Natasha M. Copeland, Institute’s/Center’s home page: Bethesda, MD 20892–9823, (240) 669–5069, www.nei.nih.gov, where an agenda and any lrust@niaid.nih.gov. Program Analyst, Office of Federal Advisory Committee Policy. additional information for the meeting will (Catalogue of Federal Domestic Assistance be posted when available. [FR Doc. 2016–21121 Filed 9–1–16; 8:45 am] Program Nos. 93.855, Allergy, Immunology, (Catalogue of Federal Domestic Assistance and Transplantation Research; 93.856, BILLING CODE 4140–01–P Program Nos. 93.867, Vision Research, Microbiology and Infectious Diseases National Institutes of Health, HHS) Research, National Institutes of Health, HHS) VerDate Sep<11>2014 18:25 Sep 01, 2016 Jkt 238001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\02SEN1.SGM 02SEN1


Document Created: 2018-02-09 11:55:39
Document Modified: 2018-02-09 11:55:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 23, 2016.
FR Citation81 FR 60712 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR